Replies to post #5 on Adial Pharmaceuticals Inc (ADIL)

[PENNIEStoSTACKS]

"(NASDAQ:ADIL; ADILW), www.adialpharma.com, a clinical-stage biopharmaceutical company focused on the development of medicines for addiction, today announced plans to expand activities around the Company’s lead asset, AD04, beyond alcohol use disorder (AUD), to now include its potential use in patients with opioid use disorder.
William Stilley, CEO of Adial Pharmaceuticals, said, “We are expanding our activities around AD04 to include opioid use disorder (OUD) and believe this program has significant potential since the physiology and neuro-transmitters involved in opioid addiction are similar to alcohol and could be expected to be modulated by a serotonin-3 receptor antagonist.”
https://ih.advfn.com/stock-market/NASDAQ/adial-pharmaceuticals-inc-ADIL/stock-news/78881798/adial-pharmaceuticals-announces-planned-expansion